- Home
- AGEN vs VIRC Comparison
AGEN vs VIRC Comparison
Compare AGEN & VIRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AGEN
- VIRC
- Stock Information
- Founded
- AGEN 1994
- VIRC 1950
- Country
- AGEN United States
- VIRC United States
- Employees
- AGEN N/A
- VIRC N/A
- Industry
- AGEN Biotechnology: Biological Products (No Diagnostic Substances)
- VIRC Industrial Specialties
- Sector
- AGEN Health Care
- VIRC Consumer Discretionary
- Exchange
- AGEN Nasdaq
- VIRC Nasdaq
- Market Cap
- AGEN 142.8M
- VIRC 121.8M
- IPO Year
- AGEN 2000
- VIRC N/A
- Fundamental
- Price
- AGEN $4.25
- VIRC $6.84
- Analyst Decision
- AGEN Buy
- VIRC
- Analyst Count
- AGEN 2
- VIRC 0
- Target Price
- AGEN $14.50
- VIRC N/A
- AVG Volume (30 Days)
- AGEN 431.2K
- VIRC 75.7K
- Earning Date
- AGEN 11-11-2025
- VIRC 09-05-2025
- Dividend Yield
- AGEN N/A
- VIRC 1.46%
- EPS Growth
- AGEN N/A
- VIRC N/A
- EPS
- AGEN N/A
- VIRC 0.84
- Revenue
- AGEN $101,706,000.00
- VIRC $236,926,000.00
- Revenue This Year
- AGEN $60.49
- VIRC $0.81
- Revenue Next Year
- AGEN N/A
- VIRC $4.56
- P/E Ratio
- AGEN N/A
- VIRC $8.12
- Revenue Growth
- AGEN N/A
- VIRC N/A
- 52 Week Low
- AGEN $1.38
- VIRC $6.76
- 52 Week High
- AGEN $7.34
- VIRC $17.31
- Technical
- Relative Strength Index (RSI)
- AGEN 45.64
- VIRC 24.10
- Support Level
- AGEN $3.78
- VIRC $7.74
- Resistance Level
- AGEN $4.38
- VIRC $7.56
- Average True Range (ATR)
- AGEN 0.24
- VIRC 0.21
- MACD
- AGEN 0.00
- VIRC -0.09
- Stochastic Oscillator
- AGEN 47.55
- VIRC 3.87
About AGEN Agenus Inc.
Agenus Inc is an American clinical-stage company with a pipeline of therapies designed to activate the body's immune system to fight cancer and infections, including immune-modulatory antibodies, adoptive cell therapies through its subsidiary MiNK Therapeutics Inc. and vaccine adjuvants through its subsidiary SaponiQx Inc. This robust product pipeline is supported by company's in-house capabilities, including current good manufacturing practice (cGMP) manufacturing and a clinical operations platform. The company's antibody candidates are botensilimab (a proprietary next-generation Fc-engineered CTLA-4 antibody, also known as AGEN1811) and balstilimab (a PD-1 antibody).
About VIRC Virco Manufacturing Corporation
Virco Manufacturing Corp is engaged in designing, production and distributing quality furniture for the commercial and education markets. The company manufactures an assortment of products, including mobile tables, mobile storage equipment, desks, computer furniture, chairs, and activity tables, folding chairs, and folding tables. Its primary furniture lines are constructed of tubular metal legs and frames, combined with wood and plastic tops, plastic seats and backs, upholstered seats and backs, and upholstered rigid polyethylene and polypropylene shells.